Oncolytic Virus Immunotherapy Market Size, Share, Demand, and Forecast 2032

Oncolytic Virus Immunotherapy Market

Oncolytic Virus Immunotherapy Market - By Application (Melanoma, Myeloma, Bladder Cancer, Ovarian Cancer, Prostrate Cancer, Lung Cancer, and Breast Cancer), By Product Type (HSV-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Adenovirus-based Oncolytic Viruses, Newcastle Disease Virus-based Oncolytic Viruses, and Vesicular Stomatitis Virus-based Oncolytic Viruses), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032-

Category: Pharmaceutical Report Format : PDF Pages: 150 Report Code: ZMR-6593 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 2.70 Billion USD 4.75 Billion 6.5% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Onculytic Virus Immunotherapy Market, 2018–2028(USD Million)
    • 2.2. Onculytic Virus Immunotherapy Market: Snapshot
  • Chapter 3. Global Onculytic Virus Immunotherapy Market– Industry Analysis
    • 3.1. Onculytic Virus Immunotherapy Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Insights into mechanisms of virus replication, entry, induction, and immune response suppression has led to use of virus for treating human diseases along with selecting onculytic viral vectors for treating specific type of cancers. This will boost growth of onculytic virus immunotherapy market in coming years.
      • 3.2.2. Immunotherapy is a major onculogy therapy targeting tumor biulogy and onculytic virus immunotherapy being most prominent among it. Additionally, the latter provides multimodal approach for effectively killing malignant cancer cells. This has resulted in humungous utility of onculytic virus immunotherapy in treating cancer, thereby driving industry trends.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Application
      • 3.4.2. Market attractiveness analysis By Product Type
  • Chapter 4. Global Onculytic Virus Immunotherapy Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Onculytic Virus Immunotherapy Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Onculytic Virus Immunotherapy Market– Application Analysis
    • 5.1. Global Onculytic Virus Immunotherapy Market overview: By Application
      • 5.1.1. Global Onculytic Virus Immunotherapy Market share, By Application, 2020 and 2028
    • 5.2. Melanoma
      • 5.2.1. Global Onculytic Virus Immunotherapy Market by Melanoma, 2018–2028(USD Million)
    • 5.3. Myeloma
      • 5.3.1. Global Onculytic Virus Immunotherapy Market by Myeloma, 2018–2028(USD Million)
    • 5.4. Bladder Cancer
      • 5.4.1. Global Onculytic Virus Immunotherapy Market by Bladder Cancer, 2018–2028(USD Million)
    • 5.5. Prostrate Cancer
      • 5.5.1. Global Onculytic Virus Immunotherapy Market by Prostrate Cancer, 2018–2028(USD Million)
    • 5.6. Ovarian Cancer
      • 5.6.1. Global Onculytic Virus Immunotherapy Market by Ovarian Cancer, 2018–2028(USD Million)
    • 5.7. Culorectal Cancer
      • 5.7.1. Global Onculytic Virus Immunotherapy Market by Culorectal Cancer, 2018–2028(USD Million)
    • 5.8. Lung Cancer
      • 5.8.1. Global Onculytic Virus Immunotherapy Market by Lung Cancer, 2018–2028(USD Million)
    • 5.9. Breast Cancer
      • 5.9.1. Global Onculytic Virus Immunotherapy Market by Breast Cancer, 2018–2028(USD Million)
  • Chapter 6. Global Onculytic Virus Immunotherapy Market– Product Type Analysis
    • 6.1. Global Onculytic Virus Immunotherapy Market overview: By Product Type
      • 6.1.1. Global Onculytic Virus Immunotherapy Market share, By Product Type, 2020 and 2028
    • 6.2. HSV-based Onculytic Viruses
      • 6.2.1. Global Onculytic Virus Immunotherapy Market by HSV-based Onculytic Viruses, 2018–2028(USD Million)
    • 6.3. Vaccinia Virus-based Onculytic Viruses
      • 6.3.1. Global Onculytic Virus Immunotherapy Market by Vaccinia Virus-based Onculytic Viruses, 2018–2028(USD Million)
    • 6.4. Vesicular Stomatitis Virus-based Onculytic Viruses
      • 6.4.1. Global Onculytic Virus Immunotherapy Market by Vesicular Stomatitis Virus-based Onculytic Viruses, 2018–2028(USD Million)
    • 6.5. Newcastle Disease Virus-based Onculytic Viruses
      • 6.5.1. Global Onculytic Virus Immunotherapy Market by Newcastle Disease Virus-based Onculytic Viruses, 2018–2028(USD Million)
    • 6.6. Adenovirus-based Onculytic Viruses
      • 6.6.1. Global Onculytic Virus Immunotherapy Market by Adenovirus-based Onculytic Viruses, 2018–2028(USD Million)
  • Chapter 7. Company Profiles
    • 7.1. Amgen, Inc.
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Genelux Corporation
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Culd Genesys, Inc.
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Development
    • 7.4. Lokon Pharma AB
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Development
    • 7.5. Takara Bio
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Viralytics Ltd.
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. Shanghai Sunway Biotech
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. Onculytics Biotech, Inc.
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. Vyriad
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. VCN Biosciences
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development
    • 7.11. Turnstone Biulogics
      • 7.11.1. Overview
      • 7.11.2. Financials
      • 7.11.3. Product Portfolio
      • 7.11.4. Business Strategy
      • 7.11.5. Recent Development
    • 7.12. Transgene sa
      • 7.12.1. Overview
      • 7.12.2. Financials
      • 7.12.3. Product Portfolio
      • 7.12.4. Business Strategy
      • 7.12.5. Recent Development
    • 7.13. DNAtrix Therapeutics
      • 7.13.1. Overview
      • 7.13.2. Financials
      • 7.13.3. Product Portfolio
      • 7.13.4. Business Strategy
      • 7.13.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Oncolytic Virus Immunotherapy Market, 2018–2028(USD Million)
4. Porter’s Five Forces Analysis
5. Global Oncolytic Virus Immunotherapy Marketattractiveness, By Application
6. Global Oncolytic Virus Immunotherapy Marketattractiveness, By Product Type
7. Global Oncolytic Virus Immunotherapy Marketshare by Application ,2020 and 2028 (USD Million)
8. Global Oncolytic Virus Immunotherapy Marketby Melanoma, 2018–2028(USD Million)
9. Global Oncolytic Virus Immunotherapy Marketby Myeloma, 2018–2028(USD Million)
10. Global Oncolytic Virus Immunotherapy Marketby Bladder Cancer, 2018–2028(USD Million)
11. Global Oncolytic Virus Immunotherapy Marketby Prostrate Cancer, 2018–2028(USD Million)
12. Global Oncolytic Virus Immunotherapy Marketby Ovarian Cancer, 2018–2028(USD Million)
13. Global Oncolytic Virus Immunotherapy Marketby Breast Cancer, 2018–2028(USD Million)
14. Global Oncolytic Virus Immunotherapy Marketby Lung Cancer, 2018–2028(USD Million)
15. Global Oncolytic Virus Immunotherapy Marketshare by Product Type ,2020 and 2028 (USD Million)
16. Global Oncolytic Virus Immunotherapy Marketby HSV-based Oncolytic Viruses, 2018–2028(USD Million)
17. Global Oncolytic Virus Immunotherapy Marketby Vaccinia Virus-based Oncolytic Viruses, 2018–2028(USD Million)
18. Global Oncolytic Virus Immunotherapy Marketby Vesicular Stomatitis Virus-based Oncolytic Viruses, 2018–2028(USD Million)
19. Global Oncolytic Virus Immunotherapy Marketby Newcastle Disease Virus-based Oncolytic Viruses, 2018–2028(USD Million)
20. Global Oncolytic Virus Immunotherapy Marketby Adenovirus-based Oncolytic Viruses, 2018–2028(USD Million)
21. Global Oncolytic Virus Immunotherapy Marketshare, by Region, 2020 and 2028
22. North America Oncolytic Virus Immunotherapy Market, 2018–2028(USD Million)
23. Europe Oncolytic Virus Immunotherapy Market, 2018–2028(USD Million)
24. Asia Pacific Oncolytic Virus Immunotherapy Market, 2018–2028(USD Million)
25. Latin America Oncolytic Virus Immunotherapy Market, 2018–2028(USD Million)
26. The Middle East and Africa Oncolytic Virus Immunotherapy Market, 2018–2028(USD Million)


Table Of Tables

List of Tables

1. Global Oncolytic Virus Immunotherapy Market: snapshot
2. Drivers of the Oncolytic Virus Immunotherapy Market: impact analysis
3. North America Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
4. North America Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
5. The U.S. Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
6. The U.S. Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
7. Rest of North America Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
8. Rest of North America Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
9. Europe Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
10. Europe Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
11. UK Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
12. UK Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
13. France Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
14. France Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
15. Germany Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
16. Germany Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
17. Rest of Europe Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
18. Rest of Europe Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
19. Asia Pacific Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
20. Asia Pacific Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
21. China Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
22. China Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
23. Japan Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
24. Japan Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
25. India Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
26. India Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
27. Rest of Asia Pacific Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
28. Rest of Asia Pacific Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
29. Latin America Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
30. Latin America Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
31. Brazil Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
32. Brazil Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
33. Rest of Latin America Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
34. Rest of Latin  America Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
35. The Middle East and Africa Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
36. The Middle East and Africa Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
37. Saudi Arabia Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
38. Saudi Arabia Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
39. South Africa Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
40. South Africa Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)
41. Rest of the Middle East & Africa Oncolytic Virus Immunotherapy Market revenue, By Application  ,2018–2028(USD Million)
42. Rest of the Middle East & Africa Oncolytic Virus Immunotherapy Market revenue, By Product Type  ,2018–2028(USD Million)

 
 

Methodology

FrequentlyAsked Questions

This therapy uses viruses to attack cancer cells. It also stimulates the immune system against tumors
The global Oncolytic Virus Immunotherapy market is expected to be driven by the advancements in cancer immunotherapy and targeted treatments. Increasing clinical trials and oncology R&D support expansion.
According to study, the global Oncolytic Virus Immunotherapy market size was worth around USD 2.70 Billion in 2023 and is predicted to grow to around USD 4.75 Billion By 2032.
The global Oncolytic Virus Immunotherapy market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 6.5% during the forecast period from 2024-2032.
The global Oncolytic Virus Immunotherapy industry is projected to be challenged by Challenges include complex clinical development and regulatory uncertainty.
The Opportunities include targeted cancer therapies, immuno-oncology research, combination treatments, and personalized medicine will offer significant growth opportunities in the Oncolytic Virus Immunotherapy market.
Genetically engineered viruses; combination with checkpoint inhibitors; personalized cancer immunotherapy approaches are the emerging trends and innovations impacting the Oncolytic Virus Immunotherapy market.
The global Oncolytic Virus Immunotherapy market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Oncolytic Virus Immunotherapy market are; Amgen, Inc., Genelux Corporation, Cold Genesys, Inc., Lokon Pharma AB, Takara Bio, Viralytics Ltd., Shanghai Sunway Biotech, Oncolytics Biotech, Inc., DNAtrix Therapeutics, Transgene sa, Turnstone Biologics, VCN Biosciences, and Vyriad. and others.
The report explores crucial aspects of the Oncolytic Virus Immunotherapy market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
  • zion payment modes

List of Contents

Market InsightsGlobalMarket SizeSynopsisGrowth DriversRegional LandscapeCompetitive LandscapeReport ScopeThe global Market is segmented as follows:

HappyClients